Daniil Gataulin
Stock Analyst at Chardan Capital
(2.68)
# 2,037
Out of 4,711 analysts
56
Total ratings
28%
Success rate
2.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGTX Cognition Therapeutics | Maintains: Buy | $11 | $0.61 | +1,691.53% | 4 | Dec 19, 2024 | |
| CRVO CervoMed | Downgrades: Neutral | n/a | $2.21 | - | 3 | Dec 11, 2024 | |
| FBRX Forte Biosciences | Maintains: Buy | $64 | $19.01 | +236.66% | 3 | Dec 4, 2024 | |
| OTLK Outlook Therapeutics | Downgrades: Neutral | n/a | $1.42 | - | 7 | Dec 2, 2024 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $7.38 | +604.61% | 8 | Nov 20, 2024 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $36 | $6.09 | +491.13% | 2 | Nov 18, 2024 | |
| OCGN Ocugen | Maintains: Buy | $6 | $0.74 | +710.70% | 7 | Nov 18, 2024 | |
| CLSD Clearside Biomedical | Maintains: Buy | $6 | $0.88 | +582.05% | 3 | Nov 15, 2024 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $28 → $33 | $7.25 | +355.17% | 8 | Nov 8, 2024 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $4 → $40 | $4.74 | +743.88% | 5 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $16.83 | +78.31% | 3 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $3.70 | +5,845.95% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.25 | - | 2 | Jul 25, 2023 |
Cognition Therapeutics
Dec 19, 2024
Maintains: Buy
Price Target: $11
Current: $0.61
Upside: +1,691.53%
CervoMed
Dec 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.21
Upside: -
Forte Biosciences
Dec 4, 2024
Maintains: Buy
Price Target: $64
Current: $19.01
Upside: +236.66%
Outlook Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.42
Upside: -
REGENXBIO
Nov 20, 2024
Maintains: Buy
Price Target: $52
Current: $7.38
Upside: +604.61%
MeiraGTx Holdings
Nov 18, 2024
Maintains: Buy
Price Target: $36
Current: $6.09
Upside: +491.13%
Ocugen
Nov 18, 2024
Maintains: Buy
Price Target: $6
Current: $0.74
Upside: +710.70%
Clearside Biomedical
Nov 15, 2024
Maintains: Buy
Price Target: $6
Current: $0.88
Upside: +582.05%
EyePoint Pharmaceuticals
Nov 8, 2024
Maintains: Buy
Price Target: $28 → $33
Current: $7.25
Upside: +355.17%
Adverum Biotechnologies
Jul 18, 2024
Maintains: Buy
Price Target: $4 → $40
Current: $4.74
Upside: +743.88%
Jun 11, 2024
Reiterates: Buy
Price Target: $30
Current: $16.83
Upside: +78.31%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $3.70
Upside: +5,845.95%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $9.25
Upside: -